Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Dearborn® Unveils New Space-Saving Sink Drain Kits Designed to Simplify Installation and Maximize Under-Sink Storage

globenewswire.com
LOW

Citizens Financial Group to Participate at the J.P. Morgan European Financials Conference

businesswire.com
CFG

Swords to Plowshares Hosts 30th Annual Veterans Day Celebration

globenewswire.com
META

Sargasso Capital Management Announces Project Kepler: The Case for Combining Tesla & SpaceX

globenewswire.com
TSLA

Rafferty Domnick Cunningham & Yaffa Spotlights Critical Patient Safety Concerns Following FDA GLP-1 Warning

globenewswire.com
LLY

Deadline Alert: Lululemon Athletica, Inc Shareholders Have Until January 4, 2027 to Seek Lead Plaintiff Appointment in Securities Fraud Lawsuit, The Law Offices of Frank R. Cruz Notes

businesswire.com
LULU

Bronstein, Gewirtz & Grossman LLC Urges AppLovin Corporation Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
APP

BigBear.ai's Pangiam Threat Detection Receives Europe-Wide ECAC Certification for Airport Security Screening

businesswire.com
BBAI

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against CVRx, Inc. (NASDAQ: CVRX) — Investors Who Suffered Losses Are Encouraged to Contact the Firm

globenewswire.com
CVRX

Type 2 Diabetes Clinical Trial and Competitive Landscape Analysis: 200+ Key Companies Shaping the Future of Type 2 Diabetes Therapeutics Space | DelveInsight

globenewswire.com
LLY NVO AZN PFE SWBI SPRO BMEA AMGN VKTX GSK SNY ALT RDHL AARD BIIB
View all news →